Shanghai Ddsome Laboratories Co., Ltd announced that it has raised series A funding on July 7, 2023. The transaction included participation from new investor Zhejiang Huahai Pharmaceutical Co., Ltd., and returning investor Zhejiang Starry Pharmaceutical Co.,Ltd.